Distension during gastroesophageal reflux: Effects of acid inhibition and correlation with symptoms

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 293, Issue 2, 2007, Pages

  Tipnis, Neelesh A ^a   Rhee, Poong Lyul ^a   Mittal, Ravinder K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intraluminal impedance; Ultrasound imaging of the esophagus

Indexed keywords

ESOMEPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ESOPHAGUS DILATATION; ESOPHAGUS PH; FEMALE; FOOD REGURGITATION; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; IMPEDANCE; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY; THORAX PAIN;

ADULT; ANTI-ULCER AGENTS; CASE-CONTROL STUDIES; DILATATION, PATHOLOGIC; ELECTRIC IMPEDANCE; ENDOSONOGRAPHY; ENZYME INHIBITORS; ESOPHAGEAL PH MONITORING; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; H(+)-K(+)-EXCHANGING ATPASE; HEARTBURN; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MANOMETRY; MIDDLE AGED; OMEPRAZOLE; PRESSURE; TREATMENT OUTCOME;

EID: 34547905341     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00019.2007     Document Type: Article

References (29)

1. Bell NJ, Hunt RH. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut 33: 118-124, 1992.
2. Bernstein LM, Baker LA. A clinical test for esophagitis. Gastroenterology 34: 760-781, 1958.
3. Bhalla V, Liu J, Puckett JL, Mittal RK. Symptom hypersensitivity to acid infusion is associated with hypersensitivity of esophageal contractility. Am J Physiol Gastrointest Liver Physiol 287: G65-G71, 2004.
4. Breumelhof R, Smout AJ. The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 86: 160-164, 1991.
5. Brunner G, Hell M, Hengels KJ, Hennig U, Fuchs W. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers. Digestion 56: 137-144, 1995.
6. Drewes AM, Reddy H, Staahl C, Pedersen J, Funch-Jensen P, Arendt-Nielsen L, Gregersen H. Sensory-motor responses to mechanical stimulation of the esophagus after sensitization with acid. World J Gastroenterol 11: 4367-4374, 2005.
7. Fass R, Naliboff B, Higa L, Johnson C, Kodner A, Munakata J, Ngo J, Mayer EA. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 115: 1363-1373, 1998.
8. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, Mitchell B, Beveridge BR, Laurence BH, Gibson GG. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 95: 903-912, 1988.
9. Hunt RH, Armstrong D, James C, Chowdhury SK, Yuan Y, Fiorentini P, Taccoen A, Cohen P. Effect on intragastric pH of a PPI with a prolonged plasma half-life: comparison between tenatoprazole and esomeprazole on the duration of acid suppression in healthy male volunteers. Am J Gastroenterol 100: 1949-1956, 2005.
10. Jenkinson AD, Scott SM, Yazaki E, Fusai G, Walker SM, Kadirkamanathan SS, Evans DF. Compliance measurement of lower esophageal sphincter and esophageal body in achalasia and gastroesophageal reflux disease. Dig Dis Sci 46: 1937-1942, 2001.
11. Mearin F, Vasconez C, Zarate N, Malagelada JR. Esophageal tone in patients with total aperistalsis: gastroesophageal reflux disease versus achalasia. Am J Physiol Gastrointest Liver Physiol 279: G374-G379, 2000.
12. Mehta AJ, De Caestecker JS, Camm AJ, Northfield TC. Sensitization to painful distention and abnormal sensory perception in the esophagus. Gastroenterology 108: 311-319, 1995.
13. Metz DC, Pratha V, Martin P, Paul J, Maton PN, Lew E, Pisegna JR. Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease. Am J Gastroenterol 95: 626-633, 2000.
14. Nguyen P, Castell DO. Stimulation of esophageal mechanoreceptors is dependent on rate and duration of distension. Am J Physiol Gastrointest Liver Physiol 267: G115-G118, 1994.
15. Pandolfino JE, Shi G, Trueworthy B, Kahrilas PJ. Esophagogastric junction opening during relaxation distinguishes nonhernia reflux patients, hernia patients, and normal subjects. Gastroenterology 125: 1018-1024, 2003.
16. Peghini PL, Katz PO, Castell DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology 115: 1335-1339, 1998.
17. Pehlivanov N, Liu J, Mittal RK. Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Gastrointest Liver Physiol 281: G743-G751, 2001.
18. Rhee PL, Liu J, Puckett JL, Mittal RK. Measuring esophageal distension by high-frequency intraluminal ultrasound probe. Am J Physiol Gastrointest Liver Physiol 283: G886-G892, 2002.
19. Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 356: 1154-1159, 2000.
20. Sarkar S, Hobson AR, Furlong PL, Woolf CJ, Thompson DG, Aziz Q. Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol 281: G1196-G1202, 2001.
21. Siddiqui MA, Johnston BT, Leite LP, Katzka DA, Castell DO. Sensitization of esophageal mucosa by prior acid infusion: effect of decreasing intervals between infusions. Am J Gastroenterol 91: 1745-1748, 1996.
22. Smith JL, Opekun AR, Larkai E, Graham DY. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 96: 683-689, 1989.
23. Srinivasan R, Vela MF, Katz PO, Tutuian R, Castell JA, Castell DO. Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol 280: G457-G462, 2001.
24. Steinbach J, Fass R, Mittal RK. Assessment of relationship between acid reflux and heartburn using receiver operating characteristic curves. Gastroenterol Clin North Am 31, Suppl 4: S45-S58, 2002.
25. Taghavi SA, Ghasedi M, Saberi-Firoozi M, Alizadeh-Naeeni M, Bagheri-Lankarani K, Kaviani MJ, Hamidpour L. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 54: 1067-1071, 2005.
26. Takeda T, Nabae T, Kassab G, Liu J, Mittal RK. Oesophageal wall stretch: the stimulus for distension induced oesophageal sensation. Neurogastroenterol Motil 16: 721-728, 2004.
27. Vakil NB, Shaker R, Johnson DA, Kovacs T, Baerg RD, Hwang C, D'Amico D, Hamelin B. The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety. Aliment Pharmacol Ther 15: 927-935, 2001.
28. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 120: 1599-1606, 2001.
29. Vidon N, Dutreuil C, Scoule JC, Delchier JC. Does lansoprazole influence postprandial digestive function? Aliment Pharmacol Ther 7: 629-634, 1993.